申请人:Adir et Compagnie
公开号:US06153640A1
公开(公告)日:2000-11-28
A compound of formula (I): ##STR1## wherein: R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, represent a group as defined in the description, R.sub.4 represents hydrogen, alky, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, or heteroarylalkyl, R.sub.5 represents aryl, or heteroaryl, each optionally substituted, n is an integer from 1 to 3 inclusive, their isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are usefull in the treatment of disease like depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety.
式(I)的化合物:##STR1## 其中:R.sub.1,R.sub.2和R.sub.3可以相同也可以不同,表示如说明书中定义的基团,R.sub.4表示氢,烷基,烯基,炔基,环烷基,环烷基烷基,芳基,芳基烷基,杂环烷基,杂环烷基烷基,杂环芳基或杂环芳基烷基,R.sub.5表示芳基或杂环芳基,每个基团都可以选择性地被取代,n是从1到3的整数,其异构体和与药用可接受酸或碱形成的加合物以及含有它们的药物制剂在治疗抑郁症、惊恐发作、强迫症、恐惧症、冲动性障碍、药物滥用或焦虑等疾病方面是有用的。